Gapping down
In reaction to disappointing earnings/guidance/SSS: CNSI -5.8%, FGP -0.4%, MCD -0.2%.
M&A news: TSN -1.5% (confirms $63 per share bid for HSH), MRK -0.8% (announces acquisition IDIX).
Other news: NSR -6.3% (confirms update on Local Number Portability Administrator Selection Process, award to go to ERIC unit), AVGO -5% (headlines over the weekend that BKS & AVGO's LSI have ended Nook related lawsuits), CRUS -2.3% (still checking), GILD -1.7% (potentially related to MRK acquistion of IDIX), RTN -0.7% (cautious Barrons mention), ACHC -0.6% (light volume, announces commencement of consent solicitation related to its 12.875% senior notes due 2018), CANF -0.5% (provides an update on its clinical developments and strategic plans).
Analyst comments: MPEL -2.7% (Cautious note on Macau at Deutsche Bank), LVS -1.9% (Cautious note on Macau at Deutsche Bank), WYNN -1.9% (Cautious note on Macau at Deutsche Bank), TOT -0.6% (downgraded downgraded to Hold from Buy at Cannacrod Genuity), ZEN -1.3% (initiated with a Neutral at Goldman, a Equal-Weight at Morgan Stanley, Neutral at CS).
In reaction to disappointing earnings/guidance/SSS: CNSI -5.8%, FGP -0.4%, MCD -0.2%.
M&A news: TSN -1.5% (confirms $63 per share bid for HSH), MRK -0.8% (announces acquisition IDIX).
Other news: NSR -6.3% (confirms update on Local Number Portability Administrator Selection Process, award to go to ERIC unit), AVGO -5% (headlines over the weekend that BKS & AVGO's LSI have ended Nook related lawsuits), CRUS -2.3% (still checking), GILD -1.7% (potentially related to MRK acquistion of IDIX), RTN -0.7% (cautious Barrons mention), ACHC -0.6% (light volume, announces commencement of consent solicitation related to its 12.875% senior notes due 2018), CANF -0.5% (provides an update on its clinical developments and strategic plans).
Analyst comments: MPEL -2.7% (Cautious note on Macau at Deutsche Bank), LVS -1.9% (Cautious note on Macau at Deutsche Bank), WYNN -1.9% (Cautious note on Macau at Deutsche Bank), TOT -0.6% (downgraded downgraded to Hold from Buy at Cannacrod Genuity), ZEN -1.3% (initiated with a Neutral at Goldman, a Equal-Weight at Morgan Stanley, Neutral at CS).